✦ LIBER ✦

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

✍ Scribed by Maurie Markman; John Blessing; Stephen C. Rubin; Joseph Connor; Parviz Hanjani; Steven Waggoner

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of docetaxel in paclita

✍ Peter G Rose; John A Blessing; Harrison G Ball; James Hoffman; David Warshal; Ko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 78 KB

A phase II trial of paclitaxel poliglume

✍ Paul Sabbatini; Michael W. Sill; David O'Malley; Lisa Adler; Angeles Alvarez Sec 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Phase II study of gemcitabine and weekly

✍ Agustin A Garcia; Anne O'Meara; Ashim Bahador; Grace Facio; Susan Jeffers; Dae-Y 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Phase I feasibility trial of carboplatin

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A phase II evaluation of nanoparticle, a

✍ Robert L. Coleman; William E. Brady; D. Scott McMeekin; Peter G. Rose; John T. S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Phase I feasibility study of intraperito

✍ Don S. Dizon; Michael W. Sill; Natalie Gould; Stephen C. Rubin; S. Diane Yamada; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB